Syncona focuses on creating commercially ambitious businesses

Syncona partner Iraj Ali talks to Informa Pharma Intelligence’s Mike Ward about the group’s investment sweet spots. Established in 2012 with USD 1 billion under management, patient capital company Syncona Partners reveals its strategy for creating and building companies that will generate reimbursable and distributed products into patients.